Clinical Trials Logo

Clinical Trial Summary

The study is aimed to assess the dose proportional total systemic exposure (when the administration is without the activated charcoal) to B17MP (active metabolite of BDP) and its lung bioavailability (when the administration is with the activated charcoal) after single inhalation of CHF 1535 NEXThaler DPI at two dose strengths. At the same time, the study will assess if the lung deposition and the total systemic exposure to Formoterol is affected by increasing doses of BDP.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01738087
Study type Interventional
Source Chiesi Farmaceutici S.p.A.
Contact
Status Completed
Phase Phase 2
Start date November 2012
Completion date January 2013

See also
  Status Clinical Trial Phase
Completed NCT05904002 - Effect of Incentive Spirometery on Asthmatic Pregnant Women N/A
Completed NCT01022931 - Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva N/A
Completed NCT02967393 - Influenza Vaccine Feasibility Study in Children With Persistent Asthma Phase 4
Completed NCT06133985 - Effects of Costovertebral Joint Mobilization on Respiratory Function in Asthmatic Patients N/A
Completed NCT04650464 - Cardiopulmonary Fitness in Children With Asthma Versus Healthy Children
Completed NCT04267666 - Inspiratory Muscle Strength Training and Incentive Spirometer on Postmenopausal Asthmatic Women N/A
Completed NCT02383069 - Pulmonary Rehabilitation in Asthmatic Patient N/A
Recruiting NCT05915845 - Laura Mitchell's Relaxation Versus Papworth Exercise in Ashmatic Patient N/A
Completed NCT00836368 - In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics Phase 1
Completed NCT02227394 - Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients Phase 2